Condition
3-methylcrotonyl-CoA Carboxylase Deficiency
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
6 treatments under study, led by Obtaining Dry Blood Spots From Highrisk Newborns Aged 17 Days
Related Conditions
Often studied with 20 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Obtaining Dry Blood Spots From Highrisk Newborns Aged 17 Days1
- Obtaining Dry Blood Spots From Healthy Children Aged 8 Days 7 Years1
- Obtaining Dry Blood Spots From Healthy Children Aged 818 Years1
- Obtaining Dry Blood Spots From Healthy Newborns Aged 17 Days1
- Obtaining Dry Blood Spots From Highrisk Childrens Aged 8 18 Years1
Active Sponsors
- West Kazakhstan Medical University1
Top Investigators
West Kazakhstan Medical University
West Kazakhstan Medical University
West Kazakhstan Medical University
Related Conditions
- Carnitineacylcarnitine Translocase Deficiency1
- Mediumchain Acylcoa Dehydrogenase Deficiency1
- Nonketotic Hyperglycinemia1
- Glutaric Acidemia Type I1
- Isovaleric Acidemia1